Fay Crawford

3.1k total citations
51 papers, 1.8k citations indexed

About

Fay Crawford is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Rehabilitation. According to data from OpenAlex, Fay Crawford has authored 51 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Surgery, 13 papers in Endocrinology, Diabetes and Metabolism and 12 papers in Rehabilitation. Recurrent topics in Fay Crawford's work include Diabetic Foot Ulcer Assessment and Management (13 papers), Wound Healing and Treatments (11 papers) and Pressure Ulcer Prevention and Management (9 papers). Fay Crawford is often cited by papers focused on Diabetic Foot Ulcer Assessment and Management (13 papers), Wound Healing and Treatments (11 papers) and Pressure Ulcer Prevention and Management (9 papers). Fay Crawford collaborates with scholars based in United Kingdom, Singapore and United States. Fay Crawford's co-authors include Francesca M. Chappell, Dianne L. Atkins, J Edwards, Sally Hollis, Alina Andras, Jos Kleijnen, Gordon Murray, Karen Welch, Tom Fahey and Phillip M. Young and has published in prestigious journals such as PLoS ONE, Cochrane Database of Systematic Reviews and Diabetologia.

In The Last Decade

Fay Crawford

49 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fay Crawford United Kingdom 22 474 461 461 379 349 51 1.8k
Sally EM Bell-Syer United Kingdom 24 323 0.7× 781 1.7× 595 1.3× 291 0.8× 158 0.5× 34 2.4k
Agnès Hartemann–Heurtier France 16 68 0.1× 365 0.8× 1.3k 2.9× 571 1.5× 51 0.1× 34 1.8k
Randall E. Marcus United States 31 448 0.9× 1.1k 2.4× 468 1.0× 361 1.0× 144 0.4× 93 2.5k
Fraser Birrell United Kingdom 29 344 0.7× 1.1k 2.3× 77 0.2× 111 0.3× 35 0.1× 71 2.8k
Ole Hoffstad United States 38 59 0.1× 693 1.5× 1.6k 3.5× 356 0.9× 84 0.2× 93 4.4k
Matthew B. Klein United States 22 274 0.6× 506 1.1× 21 0.0× 430 1.1× 80 0.2× 59 1.5k
P. Holstein Denmark 31 256 0.5× 1.8k 4.0× 3.6k 7.8× 211 0.6× 26 0.1× 99 4.6k
Lawrence B. Harkless United States 33 496 1.0× 1.2k 2.6× 4.7k 10.3× 285 0.8× 104 0.3× 61 5.6k
Makoto Oe Japan 22 37 0.1× 185 0.4× 531 1.2× 66 0.2× 25 0.1× 90 1.2k
Roelf S. Breederveld Netherlands 22 193 0.4× 637 1.4× 66 0.1× 683 1.8× 76 0.2× 74 1.7k

Countries citing papers authored by Fay Crawford

Since Specialization
Citations

This map shows the geographic impact of Fay Crawford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fay Crawford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fay Crawford more than expected).

Fields of papers citing papers by Fay Crawford

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fay Crawford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fay Crawford. The network helps show where Fay Crawford may publish in the future.

Co-authorship network of co-authors of Fay Crawford

This figure shows the co-authorship network connecting the top 25 collaborators of Fay Crawford. A scholar is included among the top collaborators of Fay Crawford based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fay Crawford. Fay Crawford is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Crawford, Fay, et al.. (2023). The 10‐year follow‐up of a community‐based cohort of people with diabetes: The incidence of foot ulceration and death. Endocrinology Diabetes & Metabolism. 7(1). e459–e459. 1 indexed citations
2.
Chappell, Francesca M., Fay Crawford, Margaret Horne, et al.. (2021). Development and validation of a clinical prediction rule for development of diabetic foot ulceration: an analysis of data from five cohort studies. BMJ Open Diabetes Research & Care. 9(1). e002150–e002150. 10 indexed citations
3.
Crawford, Fay, Francesca M. Chappell, James Lewsey, et al.. (2020). Risk assessments and structured care interventions for prevention of foot ulceration in diabetes: development and validation of a prognostic model. Health Technology Assessment. 24(62). 1–198. 17 indexed citations
4.
Heggie, Robert, Francesca M. Chappell, Fay Crawford, et al.. (2020). Complication rate among people with diabetes at low risk of foot ulceration in Fife, UK: an analysis of routinely collected data. Diabetic Medicine. 37(12). 2116–2123. 6 indexed citations
5.
Crawford, Fay, Donald Nicolson, Angela Martin, et al.. (2019). Preventing foot ulceration in diabetes: systematic review and meta-analyses of RCT data. Diabetologia. 63(1). 49–64. 45 indexed citations
6.
7.
Hayman, Rachel, et al.. (2013). The Impact of Official Development Aid on Maternal and Reproductive Health Outcomes: A Systematic Review. PLoS ONE. 8(2). e56271–e56271. 17 indexed citations
8.
Andras, Alina, et al.. (2012). Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism. Cochrane Database of Systematic Reviews. 10. CD002001–CD002001. 31 indexed citations
9.
Crawford, Fay, Colin McCowan, Borislav D. Dimitrov, et al.. (2010). The risk of foot ulceration in people with diabetes screened in community settings: findings from a cohort study. QJM. 104(5). 403–410. 52 indexed citations
10.
Crawford, Fay, Hilary Bekker, Matthew Young, & Aziz Sheikh. (2010). General practitioners' and nurses' experiences of usingcomputerised decision support in screening for diabetic footdisease: implementing Scottish Clinical Information - Diabetes Carein routine clinical practice. Journal of Innovation in Health Informatics. 18(4). 259–268. 10 indexed citations
11.
Crawford, Fay. (2008). Athlete's Foot. PubMed. 2006(11). 358–361. 14 indexed citations
12.
Crawford, Fay, Ronald M. Harris, & Hywel C Williams. (2008). Are placebo-controlled trials of creams for athlete’s foot still justified?. British Journal of Dermatology. 159(4). 773–779. 9 indexed citations
13.
Thomson, Colin E, Fay Crawford, & Gordon Murray. (2005). The effectiveness of extra corporeal shock wave therapy for plantar heel pain: a systematic review and meta-analysis. BMC Musculoskeletal Disorders. 6(1). 19–19. 88 indexed citations
14.
15.
Bell-Syer, Sally EM, et al.. (2002). Oral treatments for fungal infections of the skin of the foot.. Cochrane Database of Systematic Reviews. CD003584–CD003584. 25 indexed citations
16.
Crawford, Fay. (2001). Extracts from "Clinical Evidence": Athlete's foot and fungally infected toenails. BMJ. 322(7281). 288–289. 8 indexed citations
17.
Crawford, Fay, et al.. (1999). Topical treatments for fungal infections of the skin and nails of the foot. Cochrane Database of Systematic Reviews. CD001434–CD001434. 24 indexed citations
18.
Crawford, Fay, Dianne L. Atkins, Phillip M. Young, & J Edwards. (1999). Steroid injection for heel pain: evidence of short-term effectiveness. A randomized controlled trial. Lara D. Veeken. 38(10). 974–977. 155 indexed citations
19.
Bell-Syer, Sally EM, et al.. (1999). Systematic review of topical treatments for fungal infections of the skin and nails of the feet. BMJ. 319(7202). 79–82. 59 indexed citations
20.
Wheatley, Daniel, et al.. (1994). A ten-year study of the Ionescu-Shiley low-profile bioprosthetic heart valve. European Journal of Cardio-Thoracic Surgery. 8(10). 541–548. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sally EM Bell-Syer Breakdown of academic impact, for papers by Agnès Hartemann–Heurtier Breakdown of academic impact, for papers by Randall E. Marcus Breakdown of academic impact, for papers by Fraser Birrell Breakdown of academic impact, for papers by Ole Hoffstad Breakdown of academic impact, for papers by Matthew B. Klein Breakdown of academic impact, for papers by P. Holstein Breakdown of academic impact, for papers by Lawrence B. Harkless Breakdown of academic impact, for papers by Makoto Oe Breakdown of academic impact, for papers by Roelf S. Breederveld
Rankless by CCL
2026